Insider · CIK 0002009130
Nicholas Conrad Smith
cfoofficerpresident
Files at ANRO (Alto Neuroscience, Inc.). First filing Oct 1, 2026, latest Oct 1, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $3.6M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ANRO: Alto Neuroscience, Inc.
ANROOct 9, 2026 · close 24.37
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 32Weak | Alto Neuroscience, Inc. | $3.6M 134,886 shares | -100% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | ANRO Alto Neuroscience, Inc. | MOption exercise Common Stock | +55,000 | $2.32 | $128k | 79,060 | 7 d ago |
| Oct 2, 2026 | ANRO Alto Neuroscience, Inc. | MOption exercise Employee Stock Option (Right to Buy)derivative | -55,000 | $0.00 | $0 | 57,405 | 7 d ago |
| Sep 29, 2026 | ANRO Alto Neuroscience, Inc. | MOption exercise Common Stock10b5-1 | +56,455 | $2.35 | $133k | 80,515 | 11 d ago |
| Sep 29, 2026 | ANRO Alto Neuroscience, Inc. | MOption exercise Common Stock10b5-1 | +54,375 | $2.35 | $128k | 134,890 | 11 d ago |
| Sep 29, 2026 | ANRO Alto Neuroscience, Inc. | SOpen-market sale Common Stock10b5-1 | -110,830 | $26.58 | $2.9M | 24,060 | 11 d ago |
| Sep 30, 2026 | ANRO Alto Neuroscience, Inc. | MOption exercise Common Stock10b5-1 | +24,056 | $2.35 | $57k | 48,116 | 11 d ago |
| Sep 30, 2026 | ANRO Alto Neuroscience, Inc. | SOpen-market sale Common Stock10b5-1 | -23,170 | $25.78 | $597k | 24,946 | 11 d ago |
| Sep 30, 2026 | ANRO Alto Neuroscience, Inc. | SOpen-market sale Common Stock10b5-1 | -886 | $26.87 | $24k | 24,060 | 11 d ago |
| Sep 29, 2026 | ANRO Alto Neuroscience, Inc. | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -56,455 | $0.00 | $0 | 145,874 | 11 d ago |
| Sep 29, 2026 | ANRO Alto Neuroscience, Inc. | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -54,375 | $0.00 | $0 | 35,625 | 11 d ago |
| Sep 30, 2026 | ANRO Alto Neuroscience, Inc. | MOption exercise Employee Stock Option (Right to Buy)derivative10b5-1 | -24,056 | $0.00 | $0 | 121,818 | 11 d ago |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +44,962 | - | - | 44,962 | Jul 8, 2025 |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -44,962 | - | - | 0 | Jul 8, 2025 |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +33,833 | - | - | 33,833 | Jul 8, 2025 |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -33,833 | - | - | 0 | Jul 8, 2025 |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +202,329 | - | - | 202,329 | Jul 8, 2025 |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -202,329 | - | - | 0 | Jul 8, 2025 |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +90,000 | - | - | 90,000 | Jul 8, 2025 |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -90,000 | - | - | 0 | Jul 8, 2025 |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +135,000 | - | - | 135,000 | Jul 8, 2025 |
| Jul 3, 2025 | ANRO Alto Neuroscience, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -135,000 | - | - | 0 | Jul 8, 2025 |
| Feb 5, 2025 | ANRO Alto Neuroscience, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +135,000 | $0.00 | $0 | 135,000 | Feb 7, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.